Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients.

Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients. J Clin Invest. 2015 Aug 03; 125(8):3285-96.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.